GlassScriptPhysician profile
David Jonathan Levine
NPI 1881693877
$6,474.33
in general payments reported to CMS, 2019-2025
22 companies · $109 in 2025
The $109 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,253 · 2020: $704 · 2021: $831 · 2022: $2,184 · 2023: $837 · 2024: $556 · 2025: $109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,502.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,502.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $2,375.88 | 2019-2023 | |
| Amgen INC. | $1,338.14 | 2019-2024 | Otezla |
| Abbvie INC. | $1,007.20 | 2019-2024 | |
| Regeneron Healthcare Solutions, INC. | $385.48 | 2019-2024 | Dupixent |
| Incyte Corporation | $248.55 | 2022-2024 | Opzelura |
| Celgene Corporation | $243.17 | 2019 | |
| Ucb, INC. | $161.40 | 2021-2025 | Bimzelx, Cimzia |
| Genzyme Corporation | $140.20 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $93.24 | 2023-2025 | |
| Leo Pharma INC. | $88.20 | 2021-2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $68.66 | 2020-2024 | Jublia |
| Dermavant Sciences, INC. | $63.46 | 2022-2024 | Vtama |
| Inspire Medical Systems, INC. | $47.94 | 2024 | Inspire |
| Mayne Pharma Commercial LLC | $42.47 | 2020-2025 | |
| Sun Pharmaceutical Industries INC. | $35.55 | 2019-2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $30.66 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $23.99 | 2023 | Sotyktu |
| Lilly USA, LLC | $19.86 | 2025 | Ebglyss |
| Vyne Pharmaceuticals INC. | $16.39 | 2020 | |
| Botanix Sb INC | $15.90 | 2025 | Sofdra |
| Galderma Laboratories, L.P. | $14.55 | 2022 | |
| Medtronic, INC. | $13.44 | 2023 | Venaseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Levine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.